Tumor marker tests showed markedly elevated ProGRP levels (513.50 pg/mL; normal ≤67.42), with NSE (29.36 ng/mL; normal ≤16.5) and CEA (5.47 ng/mL; normal ≤4.5) also increased. This evidence concerns the gene CEACAM5 and neoplasm.